Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-2 of 2 for long segment:8902092

Written Answers — Department of Health: Medicinal Products (23 Apr 2024)

David Cullinane: 670. To ask the Minister for Health the reason reimbursement support for OzempicĀ® (Semaglutide) is only available to those with eligibility under the general medical services scheme or the long-term illness scheme, and is not available on the drugs payment scheme; and if he will make a statement on the matter. [17966/24]

Written Answers — Department of Health: Medicinal Products (23 Apr 2024)

Stephen Donnelly: ...reimbursement support to the approved indication. It is for this reason that reimbursement for Semaglutide (OzempicĀ®) is confined to those with eligibility under the General Medical Services Scheme (GMS) or the Long-Term Illness (LTI) scheme and is not made available on the Drugs Payment Scheme. In accordance with the provisions of the Health Act 1970 (as amended), eligibility for...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person